Botond Roska

Botond is a founding Director of the Institute of Molecular and Clinical Ophthalmology in Basel, Professor at the Faculty of Science and Medicine at the University of Basel and a Scientific Co-Founder of Affinia Therapeutics. He is an author on more than 80 publications in the areas of gene therapy, regulatory elements, and neuronal circuits. Botond is the recipient of multiple awards and a member of many advisory and editorial boards. Botond received his M.D. at the Semmelweis Medical School in Budapest, Hungary, and his Ph.D. in Neurobiology at the University of California, Berkeley.